Corey C. Ford

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

Pharmacy, Neurology, Pharmacotherapy +15

A Baseline for the Multivariate Comparison of Resting-State Networks

Elena A. Allen, Erik B. Erhardt, Eswar Damaraju et al. · Frontiers in Systems Neuroscience · 2011 · 1.4K citations · Full text

Life Sciences, Biostatistics, Neuroscience +17

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 512 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 424 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

Anthony Traboulsee, Jack H. Simon, L. Stone et al. · American Journal of Neuroradiology · 2015 · 337 citations · Full text

Medicine, Neurology, Radiology +17